US Stock MarketDetailed Quotes

Bicycle Therapeutics (BCYC)

Watchlist
  • 7.220
  • +0.320+4.64%
Close Jan 22 16:00 ET
  • 7.220
  • 0.0000.00%
Post 16:10 ET
500.84MMarket Cap-1.99P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bicycle Therapeutics (BCYC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
338.49%11.73M
-68.81%2.92M
-48.91%9.98M
30.76%35.28M
-30.44%3.71M
-50.00%2.68M
-17.86%9.36M
298.90%19.53M
86.52%26.98M
67.38%5.33M
Operating revenue
338.49%11.73M
-68.81%2.92M
-48.91%9.98M
30.76%35.28M
-30.44%3.71M
-50.00%2.68M
-17.86%9.36M
298.90%19.53M
86.52%26.98M
67.38%5.33M
Cost of revenue
Gross profit
Operating expense
16.98%77.44M
60.88%90.27M
55.86%79.98M
12.99%244.43M
18.49%70.8M
19.42%66.2M
2.21%56.11M
10.97%51.32M
64.99%216.33M
66.02%59.75M
Selling and administrative expenses
6.02%19.02M
19.86%19.24M
27.17%20.92M
19.44%71.46M
39.66%21.02M
15.23%17.94M
5.75%16.05M
17.23%16.45M
20.86%59.83M
33.56%15.05M
-General and administrative expense
6.02%19.02M
19.86%19.24M
27.17%20.92M
19.44%71.46M
39.66%21.02M
15.23%17.94M
5.75%16.05M
17.23%16.45M
20.86%59.83M
33.56%15.05M
Research and development costs
21.05%58.43M
77.31%71.03M
69.40%59.06M
10.52%172.97M
11.37%49.78M
21.06%48.27M
0.85%40.06M
8.24%34.86M
91.76%156.5M
80.82%44.7M
Operating profit
-3.43%-65.71M
-86.85%-87.35M
-120.23%-70.01M
-10.46%-209.15M
-23.29%-67.09M
-26.84%-63.53M
-7.46%-46.75M
23.13%-31.79M
-62.32%-189.35M
-65.89%-54.42M
Net non-operating interest income expense
-36.91%6.66M
6.75%7.42M
74.12%8.36M
203.14%32.55M
87.88%10.25M
232.70%10.55M
77,322.22%6.95M
126.45%4.8M
345.23%10.74M
200.94%5.46M
Non-operating interest income
-36.69%6.7M
-3.87%7.47M
49.61%8.41M
144.85%34.28M
64.17%10.3M
165.57%10.58M
857.39%7.77M
92.01%5.62M
143.26%14M
137.82%6.28M
Non-operating interest expense
33.33%44K
-93.45%54K
-93.79%51K
-46.98%1.73M
-93.66%52K
-95.95%33K
0.37%824K
1.61%821K
-2.42%3.26M
-0.73%820K
Other net income (expense)
112.41%158K
637.62%745K
-380.28%-199K
571.89%2.8M
2,033.33%3.9M
-78.29%-1.27M
-74.10%101K
115.67%71K
-594K
183K
Gain on sale of security
149.53%158K
637.62%745K
-380.28%-199K
-21.04%-719K
-412.57%-572K
55.32%-319K
-74.10%101K
115.67%71K
---594K
--183K
Special income (charges)
--0
----
----
---954K
--0
---954K
----
----
--0
--0
-Less:Other special charges
----
----
----
--954K
--0
--954K
----
----
----
----
Other non- operating income (expenses)
----
----
----
--4.48M
----
----
----
----
----
----
Income before tax
-8.56%-58.9M
-99.47%-79.18M
-129.78%-61.84M
3.02%-173.8M
-8.52%-52.94M
-13.91%-54.25M
7.94%-39.7M
32.18%-26.91M
-56.87%-179.21M
-60.47%-48.78M
Income tax
105.95%205K
-300.87%-231K
-210.57%-1.09M
-427.04%-4.77M
-438.13%-1.08M
-251.76%-3.45M
122.24%115K
43.37%-350K
195.60%1.46M
176.19%320K
Net income
-16.33%-59.1M
-98.31%-78.95M
-128.72%-60.75M
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
Net income continuous Operations
-16.33%-59.1M
-98.31%-78.95M
-128.72%-60.75M
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
Minority interest income
Net income attributable to the parent company
-16.33%-59.1M
-98.31%-78.95M
-128.72%-60.75M
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.33%-59.1M
-98.31%-78.95M
-128.72%-60.75M
6.44%-169.03M
-5.61%-51.85M
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
Basic earnings per share
-14.86%-0.85
-48.05%-1.14
-41.94%-0.88
42.91%-2.9
35.34%-0.75
41.27%-0.74
45.39%-0.77
52.31%-0.62
-33.68%-5.08
-14.85%-1.16
Diluted earnings per share
-14.86%-0.85
-48.05%-1.14
-41.94%-0.88
42.91%-2.9
35.34%-0.75
41.27%-0.74
45.39%-0.77
52.31%-0.62
-33.68%-5.08
-14.85%-1.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 338.49%11.73M-68.81%2.92M-48.91%9.98M30.76%35.28M-30.44%3.71M-50.00%2.68M-17.86%9.36M298.90%19.53M86.52%26.98M67.38%5.33M
Operating revenue 338.49%11.73M-68.81%2.92M-48.91%9.98M30.76%35.28M-30.44%3.71M-50.00%2.68M-17.86%9.36M298.90%19.53M86.52%26.98M67.38%5.33M
Cost of revenue
Gross profit
Operating expense 16.98%77.44M60.88%90.27M55.86%79.98M12.99%244.43M18.49%70.8M19.42%66.2M2.21%56.11M10.97%51.32M64.99%216.33M66.02%59.75M
Selling and administrative expenses 6.02%19.02M19.86%19.24M27.17%20.92M19.44%71.46M39.66%21.02M15.23%17.94M5.75%16.05M17.23%16.45M20.86%59.83M33.56%15.05M
-General and administrative expense 6.02%19.02M19.86%19.24M27.17%20.92M19.44%71.46M39.66%21.02M15.23%17.94M5.75%16.05M17.23%16.45M20.86%59.83M33.56%15.05M
Research and development costs 21.05%58.43M77.31%71.03M69.40%59.06M10.52%172.97M11.37%49.78M21.06%48.27M0.85%40.06M8.24%34.86M91.76%156.5M80.82%44.7M
Operating profit -3.43%-65.71M-86.85%-87.35M-120.23%-70.01M-10.46%-209.15M-23.29%-67.09M-26.84%-63.53M-7.46%-46.75M23.13%-31.79M-62.32%-189.35M-65.89%-54.42M
Net non-operating interest income expense -36.91%6.66M6.75%7.42M74.12%8.36M203.14%32.55M87.88%10.25M232.70%10.55M77,322.22%6.95M126.45%4.8M345.23%10.74M200.94%5.46M
Non-operating interest income -36.69%6.7M-3.87%7.47M49.61%8.41M144.85%34.28M64.17%10.3M165.57%10.58M857.39%7.77M92.01%5.62M143.26%14M137.82%6.28M
Non-operating interest expense 33.33%44K-93.45%54K-93.79%51K-46.98%1.73M-93.66%52K-95.95%33K0.37%824K1.61%821K-2.42%3.26M-0.73%820K
Other net income (expense) 112.41%158K637.62%745K-380.28%-199K571.89%2.8M2,033.33%3.9M-78.29%-1.27M-74.10%101K115.67%71K-594K183K
Gain on sale of security 149.53%158K637.62%745K-380.28%-199K-21.04%-719K-412.57%-572K55.32%-319K-74.10%101K115.67%71K---594K--183K
Special income (charges) --0-----------954K--0---954K----------0--0
-Less:Other special charges --------------954K--0--954K----------------
Other non- operating income (expenses) --------------4.48M------------------------
Income before tax -8.56%-58.9M-99.47%-79.18M-129.78%-61.84M3.02%-173.8M-8.52%-52.94M-13.91%-54.25M7.94%-39.7M32.18%-26.91M-56.87%-179.21M-60.47%-48.78M
Income tax 105.95%205K-300.87%-231K-210.57%-1.09M-427.04%-4.77M-438.13%-1.08M-251.76%-3.45M122.24%115K43.37%-350K195.60%1.46M176.19%320K
Net income -16.33%-59.1M-98.31%-78.95M-128.72%-60.75M6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M
Net income continuous Operations -16.33%-59.1M-98.31%-78.95M-128.72%-60.75M6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M
Minority interest income
Net income attributable to the parent company -16.33%-59.1M-98.31%-78.95M-128.72%-60.75M6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.33%-59.1M-98.31%-78.95M-128.72%-60.75M6.44%-169.03M-5.61%-51.85M-1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M
Basic earnings per share -14.86%-0.85-48.05%-1.14-41.94%-0.8842.91%-2.935.34%-0.7541.27%-0.7445.39%-0.7752.31%-0.62-33.68%-5.08-14.85%-1.16
Diluted earnings per share -14.86%-0.85-48.05%-1.14-41.94%-0.8842.91%-2.935.34%-0.7541.27%-0.7445.39%-0.7752.31%-0.62-33.68%-5.08-14.85%-1.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -